Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Mind Medicine Mindmed Inc (NQ: MNMD ) 6.360 -0.060 (-0.93%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Mind Medicine Mindmed Inc < Previous 1 2 3 4 5 6 7 8 9 ... 31 32 Next > Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch May 18, 2024 President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA). Via Benzinga Topics Cannabis Exposures Cannabis Jim Cramer: This Industrial Company Is 'Absolutely Terrific', Recommends Buying Modine Manufacturing May 15, 2024 Regarding Hertz, Jim Cramer said, "I don't want you to sell, and I don't want you to double down. Let's just see if it can't go higher." Via Benzinga Largest Clinical-Stage BioTech Drug Stocks Declined 3% Last Week May 13, 2024 Via Talk Markets Seritage Growth Properties Posts Q1 Loss, Joins Fortrea Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session May 13, 2024 Via Benzinga Top Russell 2000 Picks: 3 Small-Cap Stocks to Scoop Up This May May 10, 2024 Some of the top Russell 2000 stocks to buy are those that few investors pay attention to but offer great potential nonetheless. Via InvestorPlace MindMed to Participate at May Investor Conferences May 09, 2024 From MindMed Via Business Wire New Studies Presented at the International Society for Health Economics and Outcomes Research Meeting (ISPOR 24) Show Growing Burden and Impact of Generalized Anxiety Disorder (GAD) in the US May 09, 2024 From Mind Medicine (MindMed) Inc. Via Business Wire Biotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing Medicine May 09, 2024 These biotech breakthrough stocks give investors a glimpse into medicine's future -- and massive moneymaking opportunities to boot. Via InvestorPlace MNMD Stock Earnings: Mind Medicine Misses EPS for Q1 2024 May 08, 2024 MNMD stock results show that Mind Medicine missed analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace MindMed Reports First Quarter 2024 Financial Results and Business Updates May 08, 2024 From MindMed Via Business Wire Clinical-Stage BioTech Drug Stocks Portfolio Jumped 7% In First Week Of May May 05, 2024 We look at the performance of 10 clinical-stage AI-powered and psychedelic compound-based small cap drug discovery companies during the first week of May and YTD. Via Talk Markets MindMed Presents Phase 2b Study of MM120 for Generalized Anxiety Disorder (GAD) at American Psychiatric Association (APA) Annual Meeting in New York May 04, 2024 From MindMed Via Business Wire MindMed to Host Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Business Update May 02, 2024 From MindMed Via Business Wire The Top 3 Small-Cap Stocks to Buy in April 2024 April 25, 2024 These top small-cap stocks offer investors diversification across multiple segments but boast a strong standing on their own merits. Via InvestorPlace MindMed to Present at Upcoming May Medical Conferences April 25, 2024 From MindMed Via Business Wire This Small-Cap Stock Is Up 140% This Year and Here's Why It Can Go Even Higher April 25, 2024 For investors with a high level of risk tolerance, Mind Medicine could be an intriguing investment option. Via The Motley Fool Clinical-Stage BioTech Drug Stocks Portfolio Went Down 9% Last Week April 23, 2024 A look at the 10 clinical-stage AI-powered and psychedelic compound-based small-cap drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio, their stock performances last week and... Via Talk Markets Jim Cramer Slams Political Blocking Of 'LSD-Derived Antidepressants,' Citing Strong Test Data 'Showing They Worked' April 19, 2024 Via Benzinga Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More April 17, 2024 Via Benzinga Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More April 17, 2024 Via Benzinga The 10 Stocks In The Clinical-Stage BioTech Drug Stocks Index Are Down 4% YTD April 15, 2024 The pharmaceutical industry is embracing AI to streamline drug discovery and researching the use of psychedelic compound-based ingredients for the treatment of, as yet, untreatable diseases. Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence Largest Psychedelic Drug Stocks Up Another 10% Last Week; Now Up 54% YTD April 12, 2024 The 5 constituents in the Psychedelic Compound-Based Drug Stocks Index were up 10.0%, on average, last week and are now up 53.9% YTD. Via Talk Markets Roblox, TAL Education And Other Big Stocks Moving Higher On Wednesday April 10, 2024 U.S. stocks were lower, with the Dow Jones index falling over 300 points on Wednesday. Via Benzinga Topics Stocks Exposures US Equities Simulations Plus Posts Upbeat, Joins Levi Strauss, BlackBerry And Other Big Stocks Moving Higher In Thursday's Pre-Market Session April 04, 2024 U.S. stock futures were higher this morning, with the Dow futures gaining by around 90 points on Thursday. Via Benzinga Topics Stocks Exposures US Equities MindMed to Present at Upcoming April Medical Conferences April 02, 2024 From Mind Medicine Via Business Wire MindMed Announces Voluntary Delisting from Cboe Canada April 01, 2024 From MindMed Via Business Wire March Recap: Largest Psychedelic Drug Stocks Up Another 5% March 30, 2024 The 5 constituents in the munKNEE Psychedelic Compound-Based Drug Stocks Index were UP 5.4%, on average, in March and are now UP 39.9% YTD. Via Talk Markets Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence March 29, 2024 Via Benzinga Podcast: LSD 'Deserves To Reclaim Its Spot At The Lead Of The Path For Psychedelics' Says MindMed's R. Barrow March 27, 2024 Via Benzinga Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More March 20, 2024 Via Benzinga Topics Economy Exposures Interest Rates < Previous 1 2 3 4 5 6 7 8 9 ... 31 32 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.